Fennec Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: MACD bullish cross. There are 6 published signal records.
Fennec Pharmaceuticals last closed at $10.71 (+0.75%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -119.1×. Its overall grade ranks 90 of 738 stocks in Healthcare.
About this company
Fennec Pharmaceuticals last closed at $10.71 (+0.75%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 90/738
Valuation grade D
Related stocks
- BTG plcCompetitor
Sisplatin 유발 청력손상 적응증에서 경쟁했던 주요 선행 제품/기업
- PfizerCompetitor
항암제 및 병용치료 시장에서 Fennec의 주요 타깃 환자군과 간접 경쟁
- Jazz PharmaceuticalsCompetitor
소아·희귀질환 영역의 전문의약품 상업화 경쟁사
About Fennec Pharmaceuticals
- What technical signals does Fennec Pharmaceuticals (FENC) have?
- Fennec Pharmaceuticals current technical signals: MACD bullish cross.
- Is Fennec Pharmaceuticals a cup-and-handle pattern?
- No. Fennec Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Fennec Pharmaceuticals?
- Market cap: $365.78M. Trailing 12 months PER: -119.1×. Latest quarter PBR: 9.12×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Fennec Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.